Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash Flows from Operating Activities:
Net income	$ 14,104	$ 16,557
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,949	2,587
Deferred income tax provision/(benefit)- net	575	(1,900)
Provision for bad debts	122	(38)
Stock issued for costs and expenses		2,239
Compensatory element of stock issuances		$ 27
Stock option exercised		2
(Increase) decrease in operating assets, net:
Accounts, medical receivable(s) and management fee	(3,005)	$ (4,476)
Notes receivable		12
Costs and estimated earnings in excess of billings on uncompleted contracts	649	(649)
Inventories	(13)	(596)
Prepaid expenses and other current assets	(132)	(278)
Other assets	(883)	223
Increase (decrease) in operating liabilities, net:
Accounts payable	(164)	(72)
Other current liabilities	(1,681)	(4,008)
Customer advances	79	(181)
Billings in excess of costs and estimated earnings on completed contracts		(182)
Other liabilities	1	178
Due to related medical practices		(17)
Net cash provided by operating activities	12,601	9,428
Cash Flows from Investing Activities:
Purchases of property and equipment	(2,594)	(1,774)
Cost of patents	(75)	(122)
Net cash used in investing activities	(2,669)	(1,896)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(150)	(3,431)
Proceeds received from acquisition - net	(58)	88
Distributions to noncontrolling interests	(4,455)	(4,972)
Repayment of notes receivable from employee stockholders	5	5
Net cash used in financing activities	(4,658)	(8,310)
Net Increase (Decrease) in Cash and Cash Equivalents	5,274	(778)
Cash and Cash Equivalents - Beginning of Period	10,140	8,528
Cash and Cash Equivalents - End of Period	$ 15,414	$ 7,750